| Literature DB >> 32933417 |
Mayank Goyal1,2, Johanna M Ospel1,3, Bijoy Menon1,2, Mohammed Almekhlafi1,2, Mahesh Jayaraman4, Jens Fiehler5, Marios Psychogios3, Rene Chapot6, Aad van der Lugt7, Jianmin Liu8, Pengfei Yang9, Ronit Agid10, Werner Hacke11, Melanie Walker12, Urs Fischer13, Negar Asdaghi14, Ryan McTaggart4, Padma Srivastava15, Raul G Nogueira16, Jacques Moret17, Jeffrey L Saver18, Michael D Hill1,2, Diederik Dippel19, Marc Fisher20.
Abstract
Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large vessel occlusion and has recently revolutionized stroke care. Oftentimes, ischemic core extent on baseline imaging is used to determine endovascular treatment-eligibility. There are, however, 3 fundamental issues with the core concept: First, computed tomography and magnetic resonance imaging, which are mostly used in the acute stroke setting, are not able to precisely determine whether and to what extent brain tissue is infarcted (core) or still viable, due to variability in tissue vulnerability, the phenomenon of selective neuronal loss and lack of a reliable gold standard. Second, treatment decision-making in acute stroke is multifactorial, and as such, the relative importance of single variables, including imaging factors, is reduced. Third, there are often discrepancies between core volume and clinical outcome. This review will address the uncertainty in terminology and proposes a direction towards more clarity. This theoretical exercise needs empirical data that clarify the definitions further and prove its value.Entities:
Keywords: computed tomography; magnetic resonance imaging; thrombectomy
Mesh:
Substances:
Year: 2020 PMID: 32933417 DOI: 10.1161/STROKEAHA.120.030620
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914